Jorge M Tamayo
Overview
Explore the profile of Jorge M Tamayo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
62
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lolich M, Vazquez G, Alvarez L, Tamayo J
Actas Esp Psiquiatr
. 2012 Apr;
40(2):84-92.
PMID: 22508073
Introduction: Multiple psychosocial interventions for bipolar disorder have been proposed in recent years. Therefore, we consider that a critical review of empirically validated models would be useful. Methods: A review...
2.
Tamayo J
Actas Esp Psiquiatr
. 2011 Sep;
39(5):312-30.
PMID: 21953361
A detailed review was published in 2004 on the therapeutic properties of the medications used in the treatment of bipolar disorders (Tamayo, JM et al. Actas Esp Psiquiatr 2004;32(Supl. 1):3-17)....
3.
Degenhardt E, Tamayo J, Jamal H, Gatz J, Tohen M, Durell T
Int Clin Psychopharmacol
. 2010 Dec;
26(3):141-5.
PMID: 21164352
The aim of this study was to explore the role of ethnic origin in the treatment of acute bipolar mania. Treatment outcomes were studied in a post-hoc analysis of African-American...
4.
Tamayo J, Zarate Jr C, Vieta E, Vazquez G, Tohen M
Int J Neuropsychopharmacol
. 2010 Feb;
13(6):813-32.
PMID: 20128953
In recent years, combinations of pharmacological treatments have become common for the treatment of bipolar disorder type I (BP I); however, this practice is usually not evidence-based and rarely considers...
5.
Tamayo J, Sutton V, Mattei M, Diaz B, Jamal H, Vieta E, et al.
J Clin Psychopharmacol
. 2009 Jul;
29(4):358-61.
PMID: 19593175
We studied the effectiveness of olanzapine/fluoxetine combination (OFC) treatment of bipolar depressive episode (7 weeks, study period 1 [SP1]). Study period 1 responders (mean modal daily OFC dosage, 10.8/27.8 mg)...
6.
Durell T, Pumariega A, Rothe E, Tamayo J, Baron D, Williams D
Ann Clin Psychiatry
. 2009 Feb;
21(1):26-37.
PMID: 19239830
Background: Data on the management of attention-deficit/hyperactivity disorder (ADHD) in African-American children and adolescents are limited. Methods: This study sought to evaluate the tolerability, safety, and efficacy of atomoxetine hydrochloride...
7.
Tamayo J, Pumariega A, Rothe E, Kelsey D, Allen A, Velez-Borras J, et al.
J Child Adolesc Psychopharmacol
. 2008 Feb;
18(1):44-53.
PMID: 18294088
ABSTRACT We examined the effects of atomoxetine in Latino (n = 108) versus Caucasian (n = 1090) pediatric outpatients (aged 6 to <18 years) during the first 10-11 weeks of...
8.
Tamayo J, Rovner J, Munoz R
Braz J Psychiatry
. 2007 Jul;
29(2):182-7.
PMID: 17650540
Objective: Major depression is a disease characterized by the presence of mental and somatic symptoms, the latter affecting considerably the diagnostic and therapeutic procedures and the prognosis. Method: We searched...
9.
Tamayo J, Mazzotti G, Tohen M, Gattaz W, Zapata R, Castillo J, et al.
J Clin Psychopharmacol
. 2007 Apr;
27(2):126-34.
PMID: 17414234
Data from a published double-blind randomized trial comparing olanzapine versus haloperidol in acute mania were used to address the response and tolerability of Latin American patients. Primary efficacy end point...
10.
Tamayo J, Roman K, Fumero J, Rivas M
BMC Psychiatry
. 2005 Jun;
5:28.
PMID: 15967039
Background: This study was designed to evaluate the psychiatrists' level of recognition of somatic symptoms associated to a major depressive episode (MDE) (DSM-IV-TR criteria) and the impact of those somatic...